Immunic Inc. (NASDAQ: IMUX) is 17.86% higher on its value in year-to-date trading and has touched a low of $1.11 and a high of $11.76 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The IMUX stock was last observed hovering at around $1.74 in the last trading session, with the day’s loss setting it -0.09% off its average median price target of $10.00 for the next 12 months. It is also 94.11% off the consensus price target high of $28.00 offered by 4 analysts, but current levels are 67.0% higher than the price target low of $5.00 for the same period.
Currently trading at $1.65, the stock is -6.20% and 1.48% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.94 million and changing -5.17% at the moment leaves the stock -35.70% off its SMA200. IMUX registered -72.73% loss for a year compared to 6-month gain of 25.95%. The firm has a 200-day simple moving average (SMA200) of $0.41.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The stock witnessed a 1.23% loss in the last 1 month and extending the period to 3 months gives it a -12.70%, and is -6.78% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.94% over the week and 8.82% over the month.
Distance from 52-week low is 48.65% and -85.97% from its 52-week high.
Immunic Inc. (IMUX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Immunic Inc. (IMUX) is a “Overweight”. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 1 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Immunic Inc. is expected to release its quarterly report on 08/09/2023.The EPS is expected to grow by 3.70% this year
Immunic Inc. (IMUX) Top Institutional Holders
The shares outstanding are 43.66M, and float is at 31.08M with Short Float at 10.47%.
Immunic Inc. (IMUX) Insider Activity
A total of 2 insider transactions have happened at Immunic Inc. (IMUX) in the last six months, with sales accounting for 0 and purchases happening 2 times. The most recent transaction is an insider purchase by Whaley Glenn, the company’s Chief Financial Officer. SEC filings show that Whaley Glenn bought 5,000 shares of the company’s common stock on May 15 at a price of $1.75 per share for a total of $8750.0. Following the purchase, the insider now owns 25510.0 shares.
Immunic Inc. disclosed in a document filed with the SEC on Dec 14 that Neermann Joerg (Director) bought a total of 47,000 shares of the company’s common stock. The trade occurred on Dec 14 and was made at $1.26 per share for $59032.0. Following the transaction, the insider now directly holds 100000.0 shares of the IMUX stock.
Still, SEC filings show that on Dec 13, Neermann Joerg (Director) acquired 35,000 shares at an average price of $1.25 for $43610.0. The insider now directly holds 53,000 shares of Immunic Inc. (IMUX).